Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Carboplatin in Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer
NCT00660140Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Mar 2002
- Primary completion
- Jan 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, carboplatin in cholangiocarcinoma (CCA), gallbladder cancer, sponsored by Washington University School of Medicine. Started Mar 2002; status: completed.
02
Drugs
gemcitabinecarboplatin
03
Conditions
cholangiocarcinoma (CCA)gallbladder cancer
Beyond the preview
Go deeper on NCT00660140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660140.